Copyright: ©Author(s) 2026.
World J Gastroenterol. May 21, 2026; 32(19): 115332
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.115332
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.115332
Table 3 Chip primers of DDIT3 promoter
| Primer | Sequence |
| ChIP primer 1 | F: 5’-TTGCCAAACATTGCATCATC-3’ |
| R: 5’-AGCGCCTGGCTGTAATCTT-3’ | |
| ChIP primer 2 | F: 5’-CAAACAGAATCGGGTCCACT-3’ |
| R: 5’-GGCAGAAGAATCGCTTGAAC-3’ | |
| ChIP primer 3 | F: 5’-ACCACATGCCTCTGTTTTC-3’ |
| R: 5’-TGTGACTCCCTGTGTGAGGA-3’ | |
| ChIP primer 4 | F: 5’-GTAGAGACGGGGTTTCACCA-3’ |
| R: 5’-TAGTCGGTCGTGAGCCTCTT-3’ | |
| ChIP primer 5 | F: 5’-CCCTTCCAAAGCCACAGTCT-3’ |
| R: 5’-TTGTGACTGGAGTGGTGTGG-3’ |
- Citation: Jiang H, Yan JH, Tang WJ, Shen B, Mo S, Wang Y, Hu DH, Dong ZX, Zhang SB. PRMT5 imposed a dual repression on DDIT3 transcription to promote the malignancy of hepatocellular carcinoma. World J Gastroenterol 2026; 32(19): 115332
- URL: https://www.wjgnet.com/1007-9327/full/v32/i19/115332.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i19.115332